Jinsha Pharmaceutical

Hunan Jinsha Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise invested by Guangdong Jiaying Pharmaceutical Co., Ltd. (stock code: 002198), and is a wholly-owned subsidiary (sole proprietorship enterprise) of Guangdong Jiaying Pharmaceutical Co., Ltd. The company was established in September 1995, and is mainly a new-type pharmaceutical company integrating scientific research, production, and sales of traditional Chinese patent medicines and Western medicines. The company's production base is located in the Lugu Industrial Park of Changsha High-tech Industrial Development Zone, which has beautiful scenery and gathers talent. The production workshops are designed and built strictly in accordance with the new GMP standards. All workshops have passed the new GMP certification, and it has become one of the first enterprises in Hunan to pass GMP certification. It has the production capacity for tablets, granules, and capsules, and has been recognized as a designated production enterprise for orthopedic and traumatology medicines in China, and a governing unit of the China Orthopedic and Traumatology Association. The company's "Zhongli" brand series products are "China Famous Trademarks", and the main varieties are all "National Essential Medicines", "National Traditional Chinese Medicine Protected Varieties", and "National Medical Insurance Class A List" products. The company's marketing network covers the whole country, with offices in 30 provincial capital cities across the country, cooperating with nearly 300 pharmaceutical distribution enterprises, and establishing relatively stable cooperative relations with more than 18,000 medical institutions. The company has its own independent research and development base and team, and cooperates with the School of Pharmaceutical Sciences of Central South University, and is committed to the research of modernization of traditional Chinese medicine and innovative drugs.